26 results
8-K
EX-99.2
PRAX
Praxis Precision Medicines Inc
17 Mar 21
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
7:17am
-19 pandemic on Praxis’ business, operations, clinical trials, supply chain, strategy, goals and anticipated timelines. Except as required … ) uncertainties and assumptions regarding the impact of the COVID-19 pandemic on Praxis’ business, operations, clinical trials, supply chain, strategy, goals
8-K
EX-99.3
PRAX
Praxis Precision Medicines Inc
9 May 22
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:04pm
and assumptions regarding the impact of the COVID-19 pandemic on our business, operations, clinical trials, supply chain, strategy, goals
8-K
EX-99.2
PRAX
Praxis Precision Medicines Inc
3 Nov 21
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2021 Financial Results
7:04am
) uncertainties and assumptions regarding the impact of the COVID-19 pandemic on our business, operations, clinical trials, supply chain, strategy
8-K
EX-99.2
PRAX
Praxis Precision Medicines Inc
8 Aug 22
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2022 Financial Results
4:04pm
herein, and (ix) uncertainties and assumptions regarding the impact of the COVID-19 pandemic on our business, operations, clinical trials, supply chain, strategy
8-K
EX-99.2
wr9 nr3is
9 May 22
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:04pm
8-K
EX-99.2
8i2zc9
11 May 21
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2021 Financial Results
8:11am
8-K
EX-99.2
r5f0y7m ig1babfky
9 Nov 22
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:03pm
8-K
EX-99.1
gvbdjbly814h y5d1g
17 Dec 21
Regulation FD Disclosure
4:40pm
8-K
EX-99.1
tjv3flezx
28 Nov 22
Regulation FD Disclosure
8:04am
8-K
EX-99.2
b6q7zy biu0oi
28 Feb 22
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
6:06am
8-K
EX-99.1
pjvbuud
10 Jan 22
Regulation FD Disclosure
4:52pm
10-Q
ibtl3jlj
23 Nov 20
Quarterly report
4:16pm
8-K
EX-99.1
1cw8f ufzlv8w
27 Apr 22
Regulation FD Disclosure
4:34pm
10-K
3iu9zs a1dqgfrxw
17 Mar 21
Annual report
8:33am
DRS
p3699g9s0qesnj9pzg
22 Jul 20
Draft registration statement
12:00am
S-1/A
l36xy u7svjq1
9 Oct 20
IPO registration (amended)
6:09am